Notice of Special Interest to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial

Sponsor: National Institutes of Health

Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (PAR-22-026)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging.

Award: NINDS intends to commit $6,500,000 total costs per year in FY 2022-2027 to fund five awards.

Due Date: November 08, 2021. All applications are due by 5 p.m. local time of applicant organization.

Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) (PAR-21-314)

Sponsor: National Institutes of Health

Due Date: October 20, 2021. All applications are due by 5 p.m. local time of applicant organization.

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) (PAR-21-315)

Sponsor: National Institutes of Health

Due Date: June 20, 2024. All applications are due by 5 p.m. local time of applicant organization.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (PAR-21-271

Sponsor: National Institutes of Health

Due Date: The first due date for New applications is October 27, 2021, by 5 p.m. local time. The first due date for Resubmission applications is November 12, 2021, by 5 p.m. local time. Standard dates apply, for all subsequent receipt dates, by 5 p.m. local time of applicant organization.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) (PAR-21-272)

Sponsor: National Institutes of Health

Due Date: The first due date for New applications is October 27, 2021 by 5 p.m. local time. The first due date for Resubmission applications is November 12, 2021 by 5 p.m. local time. Standard dates apply, for all subsequent receipt dates, by 5 p.m. local time of applicant organization.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - BESH) (PAR-21-273)

Sponsor: National Institutes of Health

Due Date: The first due date for New applications is October 27, 2021 by 5 p.m. local time. The first due date for Resubmission applications is November 12, 2021 by 5 p.m. local time. Standard dates apply, for all subsequent receipt dates, by 5 p.m. local time of applicant organization.

Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required) (PAR-21-308)

Sponsor: National Institute on Aging

Due Date: Application Receipt Date(s): Multiple dates, see announcement.

Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) (PAR-21-307)

Sponsor: National Institute on Aging

Due Date: Application Receipt Date(s): Multiple dates, see announcement.

Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (PAR-22-024)

Sponsor: National Institute of Neurological Disorders and Stroke National Institute on Aging

Due Date: Application Receipt Date(s): November 10, 2021

Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed) (PAR-22-023)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NINDS intends to commit $3,750,000 in total costs per year in FY2022-2027 to fund up to five awards contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: October 22, 2021

Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) (RFA-NS-22-001)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NINDS intends to commit $3,500,000 TC in FY 2022 to fund three to six awards.

Due Date: October 22, 2021

Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed) (RFA-NS-22-006)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NINDS intends to commit $6.5 million total costs per year in FY 2022-2027 to fund up to five awards contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: October 26, 2021

BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed) (RFA-MH-21-236)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $95M per year to fund two to four Comprehensive Centers (RFA-MH-21-235) and five to 10 Specialized Collaboratories (RFA-MH-21-236).

Due Date: November 9, 2021

BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed) (RFA-MH-21-237)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $5 million per year to fund four to eight awards.

Due Date: November 9, 2021